These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 3959651
1. [Effects of bezafibrate in patients with combined hyperlipidemia]. Vílchez Joya R, Escobar Jiménez F, Campos MM, Torres E, Orduña R, Cabrera J, Núñez J. Med Clin (Barc); 1986 Feb 08; 86(5):190-4. PubMed ID: 3959651 [No Abstract] [Full Text] [Related]
3. [Bezafibrate in the treatment of familial combined hyperlipidemia and its effect on certain parameters of lipid metabolism, particularly fibrinogen]. Urbánek R, Coufal Z. Vnitr Lek; 1998 May 08; 44(5):259-62. PubMed ID: 9820067 [Abstract] [Full Text] [Related]
5. Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia. Avisar I, Brook JG, Wolfovitz E. Eur J Intern Med; 2008 May 08; 19(3):203-8. PubMed ID: 18395165 [Abstract] [Full Text] [Related]
15. [Diabetes, hyperlipidemia and atherosclerosis]. Canaani Z. Harefuah; 1974 Jan 01; 86(1):13-7. PubMed ID: 4594779 [No Abstract] [Full Text] [Related]
16. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia]. Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T. Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538 [Abstract] [Full Text] [Related]
17. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia. Kehely A, MacMahon M, Barbir M, Wray R, Hunt BJ, Prescott RJ, Thompson GR. QJM; 1995 Jun 26; 88(6):421-7. PubMed ID: 7648234 [Abstract] [Full Text] [Related]